Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer
出版年份 2020 全文链接
标题
Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-20
DOI
10.1038/s41598-020-73659-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The role of pluripotency factors to drive stemness in gastrointestinal cancer
- (2016) Martin Müller et al. Stem Cell Research
- Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines
- (2015) Heng-Hsiung Wu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Suppression of cancer relapse and metastasis by inhibiting cancer stemness
- (2015) Youzhi Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells
- (2015) Theerawut Chanmee et al. Frontiers in Oncology
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1α in Pancreatic Cancer Cells
- (2014) Rui Wang et al. CURRENT CANCER DRUG TARGETS
- Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma
- (2014) Yoshiaki Kamikawa et al. International Journal of Clinical Oncology
- Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells
- (2013) Yuhua Lu et al. CANCER LETTERS
- MUC4-induced nuclear translocation of β-catenin: A novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer
- (2013) Xiaofei Zhi et al. CANCER LETTERS
- Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway
- (2013) C-K Huang et al. ONCOGENE
- MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
- (2013) S Nath et al. Oncogenesis
- The evolving concept of cancer and metastasis stem cells
- (2012) Irène Baccelli et al. JOURNAL OF CELL BIOLOGY
- The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family
- (2012) N Skrypek et al. ONCOGENE
- Pancreatic adenocarcinoma
- (2012) G. Bond-Smith et al. BMJ-British Medical Journal
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- IL-25 Causes Apoptosis of IL-25R-Expressing Breast Cancer Cells Without Toxicity to Nonmalignant Cells
- (2011) S. Furuta et al. Science Translational Medicine
- MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells
- (2011) Moorthy P Ponnusamy et al. Journal of Ovarian Research
- The CD4+ T-cell transcriptome and serum IgE in asthma: IL17RB and the role of sex
- (2011) Gary M Hunninghake et al. BMC Pulmonary Medicine
- MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies
- (2010) Murielle Mimeault et al. CANCER LETTERS
- Mucins and Pancreatic Cancer
- (2010) Nicolas Jonckheere et al. Cancers
- HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma
- (2008) S.-S. Liau et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started